Biopharma SHAKTI Scheme: What You Should Know About India’s New ₹10,000 Crore Healthcare Manufacturing Push
India is taking another decisive step toward strengthening its healthcare manufacturing ecosystem with the launch of the Biopharma SHAKTI Scheme, a ₹10,000 crore government-backed initiative aimed at transforming the country into a global hub for biopharmaceutical production. At a time when geopolitical disruptions, pandemic lessons, and supply chain vulnerabilities have reshaped global healthcare priorities, the scheme signals New Delhi’s intent to move decisively from dependence to dominance in critical biopharma segments. The initiative aligns with the broader vision of Atmanirbhar Bharat, but its scope goes far beyond import substitution. It…
Read More